Studies: New osteoporosis drug cuts fracture risk

$Studies: New osteoporosis drug cuts fracture risk$

UNDATED (AP) - Two studies suggest a first-of-its-kind osteoporosis drug lowers the risk of bone fractures as well as or better than current medicines.

By: Associated Press | WNCT-On Your Side
Published: August 11, 2009

» Comments | Post a Comment

UNDATED (AP) - Two studies suggest a first-of-its-kind osteoporosis drug lowers the risk of bone fractures as well as or better than current medicines.
The genetically engineered drug, called denosumab, was tested in older women and men with prostate cancer.
It's made by biotech company Amgen and is being reviewed this week by Food and Drug Administration advisers.
Wall Street sees it as a potential blockbuster crucial to Amgen's future. But given the many treatments for the bone-thinning disease, doctors see its expected high cost as a big drawback.
Denosumab is injected just under the skin just twice a year. If approved, it would compete against eight types of pills and injected medicines, including estrogen and generic and brand-name Fosamax.

Reader Comments

*Facebook Account Required to Comment. If you are not already logged into Facebook, please click the comment button to do so.

Deal of the Day

Interactive Radar

Caught On Camera

Hundreds of Marilyn Monroe look-a-likes gather to break world record

A bear and moose take the path less traveled and hundreds of Marilyn Monroe look-a-likes try to break a record. The latest video and stories that will have you talking are coming up now in Take a Look At This!